BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8969375)

  • 1. Enhanced blood conservation and improved clinical outcome after valve surgery using heparin-bonded cardiopulmonary bypass circuits.
    Shapira OM; Aldea GS; Zelingher J; Volpe C; Fitzgerald C; DeAndrade K; Lazar HL; Shemin RJ
    J Card Surg; 1996; 11(5):307-17. PubMed ID: 8969375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced blood conservation in primary coronary artery bypass surgery using heparin-bonded circuits with lower anticoagulation.
    Aldea GS; Zhang X; Memmolo CA; Shapira OM; Treanor PR; Kupferschmid JP; Lazar HL; Shemin RJ
    J Card Surg; 1996; 11(2):85-95. PubMed ID: 8811400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study.
    Aldea GS; Doursounian M; O'Gara P; Treanor P; Shapira OM; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1996 Aug; 62(2):410-7; discussion 417-8. PubMed ID: 8694599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-bonded circuits improve clinical outcomes in emergency coronary artery bypass grafting.
    Aldea GS; Lilly K; Gaudiani JM; O'Gara P; Stein D; Bao Y; Treanor P; Osman A; Shapira OM; Lazar HL; Shemin RJ
    J Card Surg; 1997; 12(6):389-97. PubMed ID: 9690498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-bonded cardiopulmonary bypass circuits reduce bleeding and transfusion requirements in proximal aortic surgery.
    Shapira OM; O'Gara P; Roy-Cutter S; Lazar HL; Shemin RJ
    J Card Surg; 2000; 15(4):229-38. PubMed ID: 11758057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective use of heparin-bonded circuits and lower anticoagulation for coronary artery bypass grafting in Jehovah's Witnesses.
    Aldea GS; Shapira OM; Treanor PR; Lazar HL; Shemin RJ
    J Card Surg; 1996; 11(1):12-7. PubMed ID: 8775330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.
    Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin.
    Nilsson J; Scicluna S; Malmkvist G; Pierre L; Algotsson L; Paulsson P; Bjursten H; Johnsson P
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):834-9. PubMed ID: 22914806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?
    Mahmood S; Bilal H; Zaman M; Tang A
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):406-14. PubMed ID: 22228288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboresistant surfaces with low-dose anticoagulation alleviate clopidogrel-related complications in patients undergoing coronary artery bypass grafting.
    Hussaini BE; Thatte HS; Rhodes BA; Treanor PR; Birjiniuk V
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):782-8. PubMed ID: 21146837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures.
    Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA
    Ann Thorac Surg; 2003 Oct; 76(4):1144-8; discussion 1148. PubMed ID: 14530001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes.
    Mangoush O; Purkayastha S; Haj-Yahia S; Kinross J; Hayward M; Bartolozzi F; Darzi A; Athanasiou T
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):1058-69. PubMed ID: 17306555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Card Surg; 2003; 18(2):140-6. PubMed ID: 12757341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technique for routine use of heparin bonded circuits with a reduced anticoagulation protocol.
    O'Gara PJ; Treanor PR; Lilly KJ; Crowley RF; Reardon DL; Khuri SF; Shemin RJ; Aldea GS
    J Extra Corpor Technol; 2000 Dec; 32(4):207-13. PubMed ID: 11194057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant aprotinin in coronary artery bypass graft operations.
    Green D; Sanders J; Eiken M; Wong CA; Frederiksen J; Joob A; Palmer A; Trowbridge A; Woodruff B; Moerch M
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):963-70. PubMed ID: 7475162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.